Phase 1b study of AVB-500 in combination with paclitaxel or pegylated liposomal doxorubicin platinum-resistant recurrent ovarian cancer
Katherine C. Fuh, Michael A. Bookman, Joyce F. Liu, Robert L. Coleman, Thomas J. Herzog, Premal H. Thaker, Bradley J. Monk, Randy L. Anderson, Gail McIntyre, Reshma Rangwala, Kathleen N. Moore
Topics & Concepts
MedicineOvarian cancerInternal medicinePaclitaxelChemotherapyBevacizumabGastroenterologyDoxorubicinCancerOncologyPharmacologyPhagocytosis and Immune RegulationCancer Research and TreatmentsMonoclonal and Polyclonal Antibodies Research